CYH33相关论文
Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell l
Objective:Activating KRAS mutations are the most common drivers in the development of non-small cell lung cancer (NSCLC)......
Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell l
Objective: Activating KRAS mutations are the most common drivers in the development of non-small cell lung cancer(NSCLC)......
